Inverness Counsel’s Elevance Health ELV Stock Holding History

Inverness Counsel’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$215K	Hold	474	–	–	0.01%	174
2022 Q2	$229K	Sell	474 -100	-17%	-$49.5K	0.01%	156
2022 Q1	$282K	Sell	574 -220	-28%	-$101K	0.01%	157
2021 Q4	$368K	Hold	794	–	–	0.01%	140
2021 Q3	$296K	Hold	794	–	–	0.01%	154
2021 Q2	$303K	Hold	794	–	–	0.01%	140
2021 Q1	$285K	Sell	794 -210	-21%	-$67.5K	0.01%	130
2020 Q4	$322K	Sell	1,004 -1,145	-53%	-$351K	0.01%	118
2020 Q3	$577K	Sell	2,149 -5,190	-71%	-$1.4M	0.03%	93
2020 Q2	$1.93M	Sell	7,339 -2,422	-25%	-$646K	0.1%	65
2020 Q1	$2.22M	Sell	9,761 -90,780	-90%	-$24.7M	0.14%	54
2019 Q4	$30.4M	Buy	100,541 +84,632	+532%	+$23.3M	1.43%	28
2019 Q3	$3.82M	Buy	+15,909	New	+$4.36M	0.2%	52

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Inverness Counsel's ELV Position: Q3 2022 in Review

Inverness Counsel held its Elevance Health (ELV) position steady in Q3 2022 at 474 shares worth $215K. The position accounts for 0.01% of the portfolio, ranked #174.

Inverness Counsel first reported a position in ELV in Q3 2019 and has held it in 13 quarters since. The position peaked at $30.4M in Q4 2019. 1,446 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

Inverness Counsel held 474 shares of Elevance Health worth $215K as of Q3 2022.
Inverness Counsel left its Elevance Health share count unchanged in Q3 2022.
Elevance Health made up 0.01% of Inverness Counsel's portfolio in Q3 2022, its #174 holding.
Inverness Counsel first reported a position in Elevance Health in Q3 2019 and has held it in 13 quarters since.
Inverness Counsel's Elevance Health position peaked at $30.4M in Q4 2019.
1,446 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.